PROSTATE SPECIFIC ANTIGEN NADIR ACHIEVED BY MEN APPARENTLY CURED OF PROSTATE CANCER BY RADIOTHERAPY
- 1 April 1999
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 161 (4) , 1199-1205
- https://doi.org/10.1016/s0022-5347(01)61631-8
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- PREDICTIVE VALUE OF PROSTATE SPECIFIC ANTIGEN NADIR AFTER SALVAGE CRYOTHERAPYJournal of Urology, 1998
- High dose-rate afterloading 192iridium prostate brachytherapy: feasibility reportInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Treatment Options for Localized Prostate Cancer Based on Pretreatment Serum Prostate Specific Antigen LevelsJournal of Urology, 1997
- PROSTATE-SPECIFIC ANTIGEN AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 1997
- Prostate-specific antigen nadir of 0.5 ng/ml or less defines disease freedom for surgically staged men irradiated for prostate cancerUrology, 1997
- Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate: Preliminary results of a phase studyInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate Cancer: The relationship between nadir level and disease-free survivalJournal of Urology, 1996
- Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostateRadiotherapy and Oncology, 1996
- Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic CarcinomaJournal of Urology, 1995